Skip to main content
. 2022 May;14(5):1342–1352. doi: 10.21037/jtd-21-1948

Table 1. Patient demographics and tumor characteristics.

Characteristic Types N Age (years) P value Sex P value
WHO classification
   Low risk thymoma A 2 60 [27–76] 0.433* Male 9; female 19 0.001#
AB 13
B1 13
   High risk thymoma B2 11 65 [31–81] Male 3; female 14
B3 6
   Thymic carcinoma 16 62.5 [30–79] Male 12; female 4
   Total 61 59 [27–81] Male 24; female 37
Comorbidities in patients with thymoma
   Myasthenia gravis 11
   Rheumatoid arthritis 1
   Systemic sclerosis 1

Data are presented as the number or the mean [range]. *, there were no significant differences in the distribution of age between thymoma (low risk and high risk) and thymic carcinoma; #, there was a significant difference in the distribution of sex between thymoma (low risk and high risk) and thymic carcinoma. WHO, World Health Organization.